SearchDictionaryMobileLogin

Anaplasia

177  relevant articles (3 outcomes, 12 trials/studies) found for this Disease

Description: Loss of structural differentiation and useful function of neoplastic cells.

Also Known As:
Anaplasias

Relationship Network

Disease Context: Research Results

Related Diseases

1. Neoplasms (Cancer)
2. Wilms Tumor (Wilm's Tumor)
3. Meningioma (Meningiomas)
4. Rhabdoid Tumor (Rhabdoid Tumors)
5. Clear Cell Sarcoma

Experts

1. Bielinska, M: 1 article (07/2004)
2. Kiupel, M: 1 article (07/2004)
3. Capen, C C: 1 article (07/2004)
4. Kiiveri, S: 1 article (07/2004)
5. Peterson, R A: 1 article (07/2004)
6. Heikinheimo, M: 1 article (07/2004)
7. Wilson, D B: 1 article (07/2004)
8. Paul, Dieter: 1 article (03/2004)
9. Chávez-Dueñas, Lucía: 1 article (03/2004)
10. Soto-Zárate, Carlos: 1 article (03/2004)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Anaplasia:
1. Keratins (Keratin)IBA
2. TamoxifenFDA LinkGeneric
3. Cyclophosphamide (Cytoxan)FDA Link
4. DNA (Deoxyribonucleic Acid)IBA
5. Estrogens (Estrogen)FDA Link
6. CollagenIBA
12/01/2002 - "Histologically, the lesion was composed of astrocytes and collagen-producing fibroblasts with no anaplasia"
06/15/2007 - "METHODS: The study included 74 adult patients with histologically confirmed medulloblastomas and retrospectively reassessed 67 cases with available slides for the presence of nodularity, collagen deposition (desmoplasia without nodules), and degree and extent of anaplasia"
01/01/2003 - "In some areas, an abundance of keloidal collagen imparted a close resemblance to a solitary fibrous tumor, making it difficult to establish the diagnosis on the initial needle biopsy, although the malignant nature of the tumor was suggested because of nuclear anaplasia"
07/01/1990 - "We have studied the ultrastructural distribution of GFAP, vimentin, FVIII/RAg and collagen IV in biopsies of human gliomas with various degree of anaplasia"
12/01/1983 - "The initial biochemical data (serum[S]-carcinoembryonic antigen, S-lactate dehydrogenase, S-gammaglutamyl transferase, S-alkaline phosphatase urine[U]-creatinine, and three urinary quantities related to collagen metabolism) and surgical pathology data (tumor size, grade of tumor anaplasia, number of positive lymph nodes, number of negative lymph nodes) were examined in 52 consecutive postmenopausal risk group II patients operated for primary breast cancer without metastatic disease (mastectomy + partial axillary resection) who participated in the Danish Breast Cancer Group's controlled clinical trial of radiation (RT) alone, and RT + levamisol"
Order ALL the reference details at left...
7. Proliferating Cell Nuclear Antigen (PCNA)IBA
8. EnzymesIBA
9. tranilast (N 5')IBA
10. Vincristine (Oncovin)FDA LinkGeneric

Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Castration
3. Nephrectomy
10/01/2006 - "Open biopsy or partial/complete nephrectomy identified anaplasia at initial diagnostic procedure in 10 of 18 children"
10/01/2006 - "RESULTS: Anaplasia was identified in 0 of 7 tumors by core needle biopsy, 3 of 9 tumors by open wedge biopsy, and in 7 of 9 cases by partial or complete nephrectomy"
01/01/1998 - "Based on a retrospective analysis of 60 cases of nephroblastoma, the author reaches the following conclusions: 1) correct diagnosis and treatment of the nephroblastoma depend on the team-work involving the surgeon, the chemotherapist and the pathologist; 2) during the macroscopic analysis the pathologist is asked to: establish/determine if the tumor penetrates the renal capsule, establish the tumor invasion into the renal sinus vessels, establish if the medial limit of the renal sinus is occupied or not by the tumor and, include the nephrectomy specimens in the category over or below 550 g; 3) during the microscopical analysis the pathologist is asked to: actually make the positive diagnosis of nephroblastoma, identify the presence or the absence of the diffuse or focal anaplasia; and 4) based on this data the surgeon will complete the staging while the chemotherapist will choose a certain protocol depending on the stage and on the presence or absence of the anaplasia."
01/01/1987 - "The renal tumor present in 7 was nephroblastoma (NB) of the classical type without anaplasia or nephroblastomatosis, bilateral in 1, and unilateral but multinodular in 2. Five underwent nephrectomy for a renal mass, and in 2 NB was found at open biopsy or at autopsy"
04/01/1999 - "RESULTS: At review of the nephrectomy slides, the diagnoses were: Wilms tumor (16 patients), with anaplasia in one case, rhabdoid tumor (2 patients), neuroblastoma (2 patients), mesoblastic nephroma (2 patients), clear cell sarcoma (1 patient), malignant teratoma (1 patient), and renal cell carcinoma (1 patient)"
Order ALL the reference details at left...
4. Transplants (Transplant)
5. Adjuvant Chemotherapy

Best Treatments:
Research Summary Report
on Anaplasia
*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 3 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>